InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Explore the detailed record of transactions filed by Watts Ryan J., Chairman & CEO. Insider active across 1 companies, notably Denali Therapeutics Inc.. Cumulatively, 25 reports have been published. Total volume traded: €6.6m. The latest transaction was filed on 11 February 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations25 total
€288,6669,491 shares@ €30.41470.011% mcap4.4% of flow
Common Stock
SEC:0001714899-22-000042:0·
€89,3982,719 shares@ €32.87890.0035% mcap2.9% of flow
Common Stock
SEC:0001714899-22-000035·
€89,3982,719 shares@ €32.87890.0035% mcap1.4% of flow
Common Stock
SEC:0001714899-22-000035:0·
€198,7075,007 shares@ €39.68580.0077% mcap6.3% of flow
Common Stock
SEC:0001714899-22-000008·
€198,7075,007 shares@ €39.68580.0077% mcap3.0% of flow
Common Stock
SEC:0001714899-22-000008:0·
062,000 shares0
Common Stock
SEC:0001714899-22-000002·
062,000 shares0
Common Stock
SEC:0001714899-22-000002:0·
€333,6418,516 shares@ €39.17820.013% mcap10.6% of flow
Common Stock
SEC:0001714899-21-000114·
€333,6418,516 shares@ €39.17820.013% mcap5.1% of flow
Common Stock
SEC:0001714899-21-000114:0·
€69,7811,659 shares@ €42.06220.0027% mcap2.2% of flow
Common Stock
SEC:0001714899-21-000097·
€69,7811,659 shares@ €42.06220.0027% mcap1.1% of flow
Common Stock
SEC:0001714899-21-000097:0·
€140,9583,304 shares@ €42.66280.0055% mcap4.5% of flow
Common Stock
SEC:0001714899-21-000093·
€140,9583,304 shares@ €42.66280.0055% mcap2.1% of flow
Common Stock
SEC:0001714899-21-000093:0·
€341,0417,441 shares@ €45.83260.013% mcap10.9% of flow
Common Stock
SEC:0001714899-21-000089·
€341,0417,441 shares@ €45.83260.013% mcap5.2% of flow
Common Stock
SEC:0001714899-21-000089:0·
€68,7631,626 shares@ €42.28970.0027% mcap2.2% of flow
Common Stock
SEC:0001714899-21-000085·
€68,7631,626 shares@ €42.28970.0027% mcap1.0% of flow
Common Stock
SEC:0001714899-21-000085:0·
€365,4718,543 shares@ €42.78020.014% mcap11.7% of flow
Common Stock
SEC:0001714899-21-000080·
€365,4718,543 shares@ €42.78020.014% mcap5.6% of flow
Common Stock
SEC:0001714899-21-000080:0·
€195,3603,030 shares@ €64.47530.0076% mcap6.2% of flow
Common Stock
SEC:0001209191-21-045422·
€195,3603,030 shares@ €64.47530.0076% mcap3.0% of flow
Common Stock
SEC:0001209191-21-045422:0·
€655,20213,127 shares@ €49.91250.025% mcap20.9% of flow
Common Stock
SEC:0001209191-21-037981·
€655,20213,127 shares@ €49.91250.025% mcap10.0% of flow
Common Stock
SEC:0001209191-21-037981:0·
€678,27213,997 shares@ €48.45840.026% mcap21.6% of flow
Common Stock
SEC:0001209191-21-030300·
€678,27213,997 shares@ €48.45840.026% mcap10.3% of flow
Common Stock
SEC:0001209191-21-030300:0·
25 of 25 declarations
About Watts Ryan J.
Ryan J. Watts is an executive at Denali Therapeutics Inc.
